14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression

Published:1997-12 Issue:1 Volume:1 Page:3-11
ISSN:1097-2765
Container-title:Molecular Cell
language:en
Short-container-title:Molecular Cell

Author:

Hermeking Heiko,Lengauer Christoph,Polyak Kornelia,He Tong-Chuan,Zhang Lin,Thiagalingam Sam,Kinzler Kenneth W,Vogelstein Bert

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference38 articles.

1. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts;Agarwal;Proc. Natl. Acad. Sci. USA,1995

2. 14-3-3 proteins on the MAP;Aitken;Trends Biochem. Sci,1995

3. Accumulation of wild-type p53 protein upon gamma-irradiation induces a G2 arrest–dependent immunoglobulin kappa light chain gene expression;Aloni-Grinstein;EMBO J,1995

4. Molecular characterization of the interferon-induced 15-kDa protein;Blomstrom;J. Biol. Chem,1986

5. Radiation induced cell cycle arrest compromised by p21 deficiency;Brugarolas;Nature,1995

Cited by 1088 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering Asian elephant TP53: TP53 retrogene knockouts activate common and unique cancer-relevant pathways;2024-09-07

2. GRK2-mediated AKT activation controls cell cycle progression and G2 checkpoint in a p53-dependent manner;Cell Death Discovery;2024-08-29

3. Stratifin-mediated activation of AKT signaling and therapeutic targetability in hepatocellular carcinoma progression;Cell Insight;2024-08

4. Serum stratifin measurement is useful for evaluating disease severity and outcomes in patients with acute exacerbation of interstitial lung disease: a retrospective study;BMC Pulmonary Medicine;2024-07-29

5. PEMF Potentiates Doxorubicin-induced Late G₂Arrest in MDA-MB-231 Breast Cancer Cells;Anticancer Research;2024-06-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3